Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

P. Kongtim, K. Adekola, D. R. Milton, R. Ramlal, A. Jimenez, J. Chen, G. Rondon, S. Ahmed, P. Kebriaei, O. Betul, C. M. Hosing, U. Popat, I. Khouri, E. Jabbour, J. E. Cortes, H. M. Kantarjian, R. E. Champlin, S. O. Ciurea

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors'. Together they form a unique fingerprint.